CSIMarket
 


Stemline Therapeutics Inc  (STML)
Other Ticker:  
 

Cumulative Stemline Therapeutics Inc's Quick Ratio for Trailing Twelve Months Period

STML's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth



STML Quick Ratio for Trailing Twelve Months Period

(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Current Liabilities Growth 46.55 % 35.01 % 6.96 % 19.84 % 31.61 %
Y / Y Cash & cash equivalent Growth 8.05 % 24.97 % 16.21 % 19.85 % 50.02 %
Quick Ratio for Trailing Twelve Months Period 4 4.31 4.37 4.34 4.34
Total Ranking # 558 # # 413 # 348 # 316
Seq. Current Liabilities Growth 1.34 % 24.62 % 22.4 % -5.2 % -6.64 %
Seq. Cash & cash equivalent Growth -16.46 % 106.89 % -23.47 % -18.31 % -3.38 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to rise in Current Liabilities in the II. Quarter to $27 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 4 below Stemline Therapeutics Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 148 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Stemline Therapeutics Inc. While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from to 558.

What is Quick Ratio?
Learn more about STML
Quick Ratio STML in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 149
Sector # 286
S&P 500 # 549


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
12.12 5.78 3.72
(Sep. 30, 2015)   (Dec 31 2018)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2019, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Newlink Genetics Corp  10.94 
Vanda Pharmaceuticals Inc.  10.81 
Principia Biopharma Inc.  10.72 
Oragenics Inc  10.52 
Proqr Therapeutics N.v.  10.49 
Kalvista Pharmaceuticals, Inc.  10.43 
Xeris Pharmaceuticals Inc  10.38 
Spring Bank Pharmaceuticals, Inc.  10.19 
Cytokinetics Inc  9.92 
Xbiotech Inc.  9.91 
Ardelyx, Inc.  9.88 
Marker Therapeutics, Inc.  9.61 
Aeglea Biotherapeutics, Inc.  9.51 
Revance Therapeutics, Inc.  9.47 
Calithera Biosciences, Inc.  9.44 
Uniqure N.v.  9.12 
Ultragenyx Pharmaceutical Inc.  9.09 
Reata Pharmaceuticals Inc  8.98 
Five Prime Therapeutics Inc  8.84 
Constellation Pharmaceuticals Inc  8.78 
Arqule Inc  8.71 
Blueprint Medicines Corporation  8.63 
Xencor Inc  8.58 
Zafgen, Inc.  8.51 
Millendo Therapeutics, Inc.  8.44 
Mei Pharma, Inc.  8.43 
Insmed Inc  8.40 
Alnylam Pharmaceuticals, Inc.  8.32 
Kala Pharmaceuticals, Inc.  8.32 
Aduro Biotech, Inc.  8.29 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HPTO's Profile

Stock Price

HPTO's Financials

Business Description

Fundamentals

Charts & Quotes

HPTO's News

Suppliers

HPTO's Competitors

Customers & Markets

Economic Indicators

HPTO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071